Koninklijke Philips N.V. (0A2M.IL)
| Previous close | 22.70 |
| Open | 25.32 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 25.26 - 25.32 |
| 52-week range | 17.13 - 25.32 |
| Volume | |
| Avg. volume | 144 |
| Market cap | 20.886B |
| Beta (5Y monthly) | 0.80 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 12 May 2022 |
| 1y target est | N/A |
- Yahoo Finance Video
Eli Lilly seeks to expand Zepbound use to treat sleep apnea
Eli Lilly (LLY) is reporting success in the use of Zepbound — one of the pharmaceutical giant's landmark GLP-1 weight-loss drugs — to treat sleep apnea. Yahoo Finance Health Reporter Anjalee Khemlani joins The Morning Brief to discuss Eli Lilly's filing for approval from the US Food and Drug Administration (FDA) for this use case and how it may affect makers of CPAP (Continuous Positive Airway Pressure) sleep devices, such as Philips (PHG) and ResMed (RMD). For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.
- Zacks
Philips' (PHG) Diagnosis & Treatment Segment Drives Growth
Philips (PHG) boosts Diagnosis & Treatment on the back of Precision Diagnosis and Image-Guided Therapy businesses and an expanding partner base.
- Yahoo Finance Video
Philips NA CEO on alleviating healthcare worker burnout
The healthcare industry faces multiple challenges, including the challenge of filling healthcare jobs. The stress of labor shortages could be causing employee burnout and may be impacting patient care, according to the Philips 2024 Future Health Index survey. Philips (PHG) North America CEO Jeff DiLullo joins Wealth! alongside Yahoo Finance Reporter Anjalee Khemlani to give insight into the current landscape of the labor market within the healthcare sector. DiLullo elaborates on the process in which many nurses and doctors are feeling burnout, specifically with how they must learn new technologies to process patient information. He claims Philips helps by simplifying that process: "From Philips' perspective, interoperability is the name of the game. If you think about the journey that we're on, you need the technology and the innovation, but it has to be organized in a way. CEOs and CIOs will tell me, 'don't kill me by a death by a thousand cuts, orchestrate it for me.' That's why we're proud to lead in our orchestration of that with an informatics platform that can look at extracting from the device, liquidating and organizing that data along the care path to interact with doctors wherever they are, not always in a hospital. " For more expert insight and the latest market action, click here to watch this full episode of Wealth! This post was written by Nicholas Jacobino
